Abcam plc

13.46+0.1600+1.20%Vol 601.88K1Y Perf -27.28%
Mar 31st, 2023 16:00 DELAYED
BID12.50 ASK15.58
Open13.21 Previous Close13.46
Pre-Market- After-Market13.46
 - -  - -%
Target Price
21.00 
Analyst Rating
Moderate Buy 2.00
Potential %
56.02 
Finscreener Ranking
★+     43.75
Insiders Trans % 3/6/12 mo.
-/100/-33 
Value Ranking
+     35.74
Insiders Value % 3/6/12 mo.
-/100/-82 
Growth Ranking
★★★     51.72
Insiders Shares Cnt. % 3/6/12 mo.
-/100/-82 
Income Ranking
★★★     46.36
Price Range Ratio 52W %
13.43 
Earnings Rating
Market Cap3.09B 
Earnings Date
20th Mar 2023
Alpha-0.02 Standard Deviation0.11
Beta1.12 

Today's Price Range

13.1313.58

52W Range

12.5419.39

5 Year PE Ratio Range

31.40301.00

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
3.70%
1 Month
-7.43%
3 Months
-13.50%
6 Months
-10.21%
1 Year
-27.28%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ABCM13.460.16001.20
AAPL164.902.54001.56
GOOG104.002.68002.65
MSFT289.275.22001.84
XOM109.660.17000.16
WFC37.380.00000.00
JNJ155.001.57001.02
FB196.640.99000.51
GE95.601.55001.65
JPM130.311.56001.21
 
ProfitabilityValueIndustryS&P 500US Markets
72.70
2.00
15.00
9.30
3.13
RevenueValueIndustryS&P 500US Markets
228.13M
1.00
18.52
16.01
DividendsValueIndustryS&P 500US Markets
-
-
47.25
-4.73
Payout ratio202.00
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report0.19
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume601.88K
Shares Outstanding229.27K
Shares Float205.52M
Trades Count5.52K
Dollar Volume8.07M
Avg. Volume639.40K
Avg. Weekly Volume571.51K
Avg. Monthly Volume705.42K
Avg. Quarterly Volume641.26K

Abcam plc (NASDAQ: ABCM) stock closed at 13.46 per share at the end of the most recent trading day (a 1.2% change compared to the prior day closing price) with a volume of 601.88K shares and market capitalization of 3.09B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 1500 people. Abcam plc CEO is Alan Thomas Hirzel.

The one-year performance of Abcam plc stock is -27.28%, while year-to-date (YTD) performance is -13.5%. ABCM stock has a five-year performance of %. Its 52-week range is between 12.54 and 19.39, which gives ABCM stock a 52-week price range ratio of 13.43%

Abcam plc currently has a PE ratio of 138.20, a price-to-book (PB) ratio of 4.21, a price-to-sale (PS) ratio of 16.47, a price to cashflow ratio of 52.70, a PEG ratio of 2.32, a ROA of 0.72%, a ROC of 0.68% and a ROE of 1.00%. The company’s profit margin is 3.13%, its EBITDA margin is 15.00%, and its revenue ttm is $228.13 Million , which makes it $1.00 revenue per share.

Of the last four earnings reports from Abcam plc, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.19 for the next earnings report. Abcam plc’s next earnings report date is -.

The consensus rating of Wall Street analysts for Abcam plc is Moderate Buy (2), with a target price of $21, which is +56.02% compared to the current price. The earnings rating for Abcam plc stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Abcam plc has a dividend yield of -% with a dividend per share of $- and a payout ratio of 202.00%.

Abcam plc has a Sell technical analysis rating based on Technical Indicators (ADX : 12.49, ATR14 : 0.55, CCI20 : -60.98, Chaikin Money Flow : -0.14, MACD : -0.42, Money Flow Index : 31.37, ROC : -3.86, RSI : 43.23, STOCH (14,3) : 26.52, STOCH RSI : 1.00, UO : 45.45, Williams %R : -73.48), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Abcam plc in the last 12-months were: Alan Thomas Hirzel (Sold 68 853 shares of value $979 090 ), Bessie Chien Ling Lee (Buy at a value of $14 637), Giles Francis Bertram Kerr (Buy at a value of $24 692), Mara Glickman Aspinall (Buy at a value of $43 624), Mark Christopher Capone (Buy at a value of $22 753), Michael Shaun Baldock (Sold 19 117 shares of value $271 551 ), Peter Vance Allen (Buy at a value of $67 281), Sally Wellinghoff Crawford (Buy at a value of $239 824)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (50.00 %)
2 (50.00 %)
2 (40.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (50.00 %)
2 (50.00 %)
3 (60.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.20

Abcam plc

Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.

CEO: Alan Thomas Hirzel

Telephone: +44 1223696000

Address: Discovery Drive, Cambridge CB2 0AX, , GB

Number of employees: 1 500

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

60%40%

Bearish Bullish

62%38%

TipRanks News for ABCM


News

Stocktwits